(-)-alpha-phellandrene increases expression ISO RGD:1318099 6480464 alpha phellandrene results in increased expression of SAMHD1 mRNA CTD PMID:25075043 1,2-dichloroethane increases expression ISO RGD:1318100 6480464 ethylene dichloride results in increased expression of SAMHD1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1318100 6480464 1, 2-Dimethylhydrazine results in decreased expression of SAMHD1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1318100 6480464 Ethinyl Estradiol affects the expression of SAMHD1 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1318099 6480464 Estradiol results in increased expression of SAMHD1 mRNA CTD PMID:21185374 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1318099 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318100 6480464 Tetrachlorodibenzodioxin affects the expression of SAMHD1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SAMHD1 mRNA CTD PMID:34747641 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1318099 6480464 2 more ... CTD PMID:26705709 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SAMHD1 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318099 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAMHD1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1318100 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SAMHD1 mRNA CTD PMID:18648102 4-hydroxynon-2-enal affects binding ISO RGD:1318099 6480464 SAMHD1 protein binds to 4-hydroxy-2-nonenal CTD PMID:20043646 4-hydroxyphenyl retinamide decreases expression ISO RGD:1318100 6480464 Fenretinide results in decreased expression of SAMHD1 mRNA CTD PMID:28973697 5-fluorouracil affects expression ISO RGD:1318099 6480464 Fluorouracil affects the expression of SAMHD1 mRNA CTD PMID:16584549 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SAMHD1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SAMHD1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1318099 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SAMHD1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of SAMHD1 mRNA CTD PMID:32699268 aflatoxin B1 increases methylation ISO RGD:1318099 6480464 Aflatoxin B1 results in increased methylation of SAMHD1 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1318099 6480464 Tretinoin results in increased expression of SAMHD1 mRNA CTD PMID:33167477 alpha-phellandrene increases expression ISO RGD:1318099 6480464 alpha phellandrene results in increased expression of SAMHD1 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:1318099 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SAMHD1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of SAMHD1 mRNA CTD PMID:32699268 antirheumatic drug decreases expression ISO RGD:1318099 6480464 Antirheumatic Agents results in decreased expression of SAMHD1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1318099 6480464 aristolochic acid I results in increased expression of SAMHD1 mRNA CTD PMID:33212167 benzo[a]pyrene increases expression ISO RGD:1318100 6480464 Benzo(a)pyrene results in increased expression of SAMHD1 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1318099 6480464 Benzo(a)pyrene results in increased expression of SAMHD1 protein CTD PMID:32717239 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1318099 6480464 Diethylhexyl Phthalate results in increased expression of SAMHD1 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1318099 6480464 Diethylhexyl Phthalate results in decreased expression of SAMHD1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SAMHD1 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases methylation ISO RGD:1318099 6480464 bisphenol A results in increased methylation of SAMHD1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SAMHD1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol F multiple interactions ISO RGD:1318099 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAMHD1 mRNA CTD PMID:28628672 caffeine decreases phosphorylation ISO RGD:1318099 6480464 Caffeine results in decreased phosphorylation of SAMHD1 protein CTD PMID:35688186 carbon nanotube affects expression ISO RGD:1318100 6480464 Nanotubes, Carbon affects the expression of SAMHD1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1318100 6480464 Nanotubes, Carbon analog results in increased expression of SAMHD1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1318100 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene decreases expression ISO RGD:1318100 6480464 Chloroprene results in decreased expression of SAMHD1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1318100 6480464 Chlorpyrifos results in decreased expression of SAMHD1 mRNA CTD PMID:32715474 chromium(6+) affects expression ISO RGD:1318100 6480464 chromium hexavalent ion affects the expression of SAMHD1 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1318099 6480464 Cisplatin results in increased expression of SAMHD1 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1318099 6480464 cobaltous chloride results in decreased expression of SAMHD1 mRNA CTD PMID:19320972 coumarin decreases phosphorylation ISO RGD:1318099 6480464 coumarin results in decreased phosphorylation of SAMHD1 protein CTD PMID:35688186 cyclosporin A decreases expression ISO RGD:1318099 6480464 Cyclosporine results in decreased expression of SAMHD1 mRNA CTD PMID:20106945 , PMID:25562108 deoxynivalenol affects phosphorylation ISO RGD:1318100 6480464 deoxynivalenol affects the phosphorylation of SAMHD1 protein CTD PMID:23811945 dexamethasone increases expression ISO RGD:1318100 6480464 Dexamethasone results in increased expression of SAMHD1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1318099 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAMHD1 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:1318099 6480464 Dexamethasone results in increased expression of SAMHD1 mRNA CTD PMID:25047013 dGTP decreases abundance ISO RGD:1318099 6480464 SAMHD1 protein results in decreased abundance of deoxyguanosine triphosphate CTD PMID:26342080 diazinon increases methylation ISO RGD:1318099 6480464 Diazinon results in increased methylation of SAMHD1 gene CTD PMID:22964155 dorsomorphin multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1318099 6480464 Doxorubicin results in decreased expression of SAMHD1 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1318099 6480464 entinostat results in increased expression of SAMHD1 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAMHD1 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1318099 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SAMHD1 protein CTD PMID:23301498 formaldehyde decreases expression ISO RGD:1318099 6480464 Formaldehyde results in decreased expression of SAMHD1 mRNA CTD PMID:23649840 Genipin multiple interactions ISO RGD:1318100 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of SAMHD1 mRNA] CTD PMID:22687549 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SAMHD1 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1318099 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAMHD1 mRNA CTD PMID:28628672 irinotecan affects expression ISO RGD:1318099 6480464 Irinotecan analog affects the expression of SAMHD1 mRNA CTD PMID:18927307 ivermectin decreases expression ISO RGD:1318099 6480464 Ivermectin results in decreased expression of SAMHD1 protein CTD PMID:32959892 leflunomide decreases expression ISO RGD:1318099 6480464 leflunomide results in decreased expression of SAMHD1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1318100 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of SAMHD1 mRNA] CTD PMID:22687549 lipopolysaccharide increases expression ISO RGD:1318099 6480464 Lipopolysaccharides results in increased expression of SAMHD1 protein CTD PMID:30501627 lipopolysaccharide increases expression ISO RGD:1318100 6480464 Lipopolysaccharides results in increased expression of SAMHD1 mRNA CTD PMID:22687549 mercury dibromide decreases expression ISO RGD:1318099 6480464 mercuric bromide results in decreased expression of SAMHD1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMHD1 mRNA CTD PMID:27188386 methyl methanesulfonate decreases expression ISO RGD:1318099 6480464 Methyl Methanesulfonate results in decreased expression of SAMHD1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1318099 6480464 methylmercuric chloride results in decreased expression of SAMHD1 mRNA CTD PMID:23179753 more ... methylmercury chloride increases expression ISO RGD:1318099 6480464 methylmercuric chloride results in increased expression of SAMHD1 mRNA CTD PMID:28001369 nickel atom decreases expression ISO RGD:1318099 6480464 Nickel results in decreased expression of SAMHD1 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1318099 6480464 Nickel results in increased expression of SAMHD1 mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions ISO RGD:1318099 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SAMHD1 mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMHD1 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1318099 6480464 Acetaminophen results in increased expression of SAMHD1 mRNA CTD PMID:26690555 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SAMHD1 mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO RGD:1318100 6480464 Pentachlorophenol results in increased expression of SAMHD1 mRNA CTD PMID:23892564 phenylmercury acetate decreases expression ISO RGD:1318099 6480464 Phenylmercuric Acetate results in decreased expression of SAMHD1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMHD1 mRNA CTD PMID:27188386 picoxystrobin increases expression ISO RGD:1318099 6480464 picoxystrobin results in increased expression of SAMHD1 mRNA CTD PMID:33512557 quercetin decreases expression ISO RGD:1318099 6480464 Quercetin results in decreased expression of SAMHD1 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1318100 6480464 Silver results in decreased expression of SAMHD1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1318100 6480464 Silver results in decreased expression of SAMHD1 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1318100 6480464 sodium arsenite results in decreased expression of SAMHD1 protein CTD PMID:29044176 sodium dichromate decreases expression ISO RGD:1318100 6480464 sodium bichromate results in decreased expression of SAMHD1 mRNA CTD PMID:22561333 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SAMHD1 mRNA CTD PMID:22561333 succimer multiple interactions ISO RGD:1318099 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SAMHD1 mRNA CTD PMID:26378955 tamoxifen affects expression ISO RGD:1318100 6480464 Tamoxifen affects the expression of SAMHD1 mRNA CTD PMID:17555576 tetrachloromethane decreases expression ISO RGD:1318100 6480464 Carbon Tetrachloride results in decreased expression of SAMHD1 protein CTD PMID:29044176 thimerosal decreases expression ISO RGD:1318099 6480464 Thimerosal results in decreased expression of SAMHD1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SAMHD1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1318099 6480464 titanium dioxide results in increased expression of SAMHD1 protein CTD PMID:30910687 trichostatin A decreases expression ISO RGD:1318099 6480464 trichostatin A results in decreased expression of SAMHD1 mRNA CTD PMID:24935251 Triptolide increases expression EXP 6480464 triptolide results in increased expression of SAMHD1 protein CTD PMID:32519852 triptonide affects expression ISO RGD:1318100 6480464 triptonide affects the expression of SAMHD1 mRNA CTD PMID:33045310 valproic acid multiple interactions ISO RGD:1318099 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAMHD1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1318099 6480464 Valproic Acid results in increased expression of SAMHD1 mRNA CTD PMID:23179753 more ... vancomycin decreases expression ISO RGD:1318100 6480464 Vancomycin results in decreased expression of SAMHD1 mRNA CTD PMID:18930951 vincristine decreases expression ISO RGD:1318099 6480464 Vincristine results in decreased expression of SAMHD1 mRNA CTD PMID:23649840
